Skip to content

Clinical trials

Fatty Liver trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fatty Liver Country / region: Australia Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20083
20171
20212
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting4
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
89bio, Inc.2
Sanofi2
Axcella Health, Inc1
Cook Research Incorporated1
Eli Lilly and Company1
Garvan Institute of Medical Research1
GlaxoSmithKline1
Inventiva Pharma1
Keogh Institute for Medical Research1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fatty Liver11
Non-alcoholic Fatty Liver Disease5
Fibrosis4
Liver Diseases4
Digestive System Diseases3
Metabolic Diseases2
Hepatitis C1
Hypertension, Portal1
Insulin Resistance1
Liver Cirrhosis1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.